Announcements

Alliance Calls for Global, Multi-Stakeholder Effort to Advance Research on COVID-19 and Progressive MS

Alliance-Funded Study Shows Potential of Blood Test in Helping to Predict Future Multiple Sclerosis Activity and Response to Therapy in Individuals

Alliance Maps Out Global Research Agenda to End Progressive MS

FDA Backs Further Development of Blood Biomarker, Neurofilament Light, for Clinical Trials in Progressive MS

International Progressive MS Alliance Funds 19 Research Challenge Awards Focused on New Insights into Progression

Alliance Receives Award from Sanofi to Speed Development of a New Biomarker for Progressive MS

Information and Resources for People with MS regarding COVID-19 and Vaccines

Study Identifies New Subtypes of MS Based on Hidden Patterns of Damage Seen on MRI Scans

Advancing Research to Reduce Symptoms Experienced by People with Progressive MS

Load more